Us Bancorp \De\ Veracyte, Inc. Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Veracyte, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,774 shares of VCYT stock, worth $74,383. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,774

Previous 1,127 57.41%

Holding current value

$74,383

Previous $38,000 84.21%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$31.92 - $44.4 $20,652 - $28,726	647 Added 57.41%	1,774 $70,000
Q3 2024 Oct 28, 2024	SELL	$21.0 - $35.25 $50,715 - $85,128	-2,415 Reduced 68.18%	1,127 $38,000
Q2 2024 Aug 06, 2024	BUY	$18.86 - $23.55 $3,526 - $4,403	187 Added 5.57%	3,542 $76,000
Q1 2024 May 07, 2024	BUY	$21.0 - $29.1 $8,442 - $11,698	402 Added 13.61%	3,355 $74,000
Q4 2023 Feb 09, 2024	BUY	$19.72 - $28.68 $354 - $516	18 Added 0.61%	2,953 $81,000
Q3 2023 Nov 03, 2023	BUY	$22.33 - $29.92 $2,567 - $3,440	115 Added 4.08%	2,935 $65,000
Q2 2023 Aug 09, 2023	BUY	$20.96 - $26.99 $1,173 - $1,511	56 Added 2.03%	2,820 $71,000
Q1 2023 May 09, 2023	BUY	$20.58 - $27.89 $617 - $836	30 Added 1.1%	2,764 $61,000
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $40,158 - $78,532	-2,623 Reduced 48.96%	2,734 $64,000
Q3 2022 Oct 27, 2022	SELL	$16.58 - $27.9 $10,926 - $18,386	-659 Reduced 10.95%	5,357 $88,000
Q2 2022 Aug 01, 2022	SELL	$15.45 - $29.52 $8,343 - $15,940	-540 Reduced 8.24%	6,016 $119,000
Q1 2022 May 11, 2022	BUY	$21.94 - $42.51 $7,371 - $14,283	336 Added 5.4%	6,556 $180,000
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $6,676 - $9,951	-185 Reduced 2.89%	6,220 $256,000
Q3 2021 Nov 10, 2021	SELL	$35.62 - $52.97 $138,918 - $206,583	-3,900 Reduced 37.85%	6,405 $297,000
Q2 2021 Aug 05, 2021	BUY	$32.94 - $56.62 $102,015 - $175,352	3,097 Added 42.97%	10,305 $413,000
Q1 2021 Apr 28, 2021	BUY	$44.47 - $81.38 $165,383 - $302,652	3,719 Added 106.59%	7,208 $387,000
Q4 2020 Feb 04, 2021	SELL	$32.49 - $61.88 $5,035 - $9,591	-155 Reduced 4.25%	3,489 $171,000
Q3 2020 Nov 10, 2020	BUY	$26.73 - $35.67 $4,143 - $5,528	155 Added 4.44%	3,644 $118,000
Q2 2020 Aug 07, 2020	SELL	$19.49 - $28.11 $13,935 - $20,098	-715 Reduced 17.01%	3,489 $90,000
Q1 2020 May 13, 2020	BUY	$16.13 - $30.17 $1,629 - $3,047	101 Added 2.46%	4,204 $103,000
Q4 2019 Feb 04, 2020	SELL	$20.78 - $29.99 $831 - $1,199	-40 Reduced 0.97%	4,103 $114,000
Q3 2019 Nov 08, 2019	BUY	$23.87 - $30.93 $29,288 - $37,951	1,227 Added 42.08%	4,143 $100,000
Q2 2019 Aug 13, 2019	BUY	$22.1 - $28.56 $54,388 - $70,286	2,461 Added 540.88%	2,916 $83,000
Q3 2018 Nov 01, 2018	BUY	$9.55 - $12.64 $4,345 - $5,751	455 New	455 $4,000

Others Institutions Holding VCYT

# of Institutions

325

Shares Held

80M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account